A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS
A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS
Not yet recruiting · NCT07169175 · Registry updated 2025-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Not yet recruiting | Phase 1 / Phase 2 | 2025-09-11 | NCT07169175 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| SineuGene Therapeutics Co., Ltd. | 2 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fujian Medical University Union Hospital | Fuzhou | China | 19 |
| Massachusetts General Hospital | Boston | United States | 1 |
| Peking University Third Hospital | Beijing | China | 21 |
| Second Affiliated Hospital Zhejiang University School of Medicine | Hangzhou | China | 2 |